These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 12567300

  • 21. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity.
    Hidayat LK, Hsu DI, Quist R, Shriner KA, Wong-Beringer A.
    Arch Intern Med; 2006 Oct 23; 166(19):2138-44. PubMed ID: 17060545
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Predictors of high vancomycin MIC values among patients with methicillin-resistant Staphylococcus aureus bacteraemia.
    Lodise TP, Miller CD, Graves J, Evans A, Graffunder E, Helmecke M, Stellrecht K.
    J Antimicrob Chemother; 2008 Nov 23; 62(5):1138-41. PubMed ID: 18694905
    [Abstract] [Full Text] [Related]

  • 25. Vancomycin intermediate and resistant Staphylococcus aureus. What the nephrologist needs to know.
    McDonald LC, Hageman JC.
    Nephrol News Issues; 2004 Oct 23; 18(11):63-4, 66-7, 71-2 passim. PubMed ID: 15551615
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Screening for Staphylococcus aureus with a reduced susceptibility to vancomycin in: a Belgian hospital].
    Piérard D, Vandenbussche H, Verschraegen I, Lauwers S.
    Pathol Biol (Paris); 2004 Oct 23; 52(8):486-8. PubMed ID: 15465269
    [Abstract] [Full Text] [Related]

  • 28. Vancomycin-intermediate Staphylococcus aureus with phenotypic susceptibility to methicillin in a patient with recurrent bacteremia.
    Naimi TS, Anderson D, O'Boyle C, Boxrud DJ, Johnson SK, Tenover FC, Lynfield R.
    Clin Infect Dis; 2003 Jun 15; 36(12):1609-12. PubMed ID: 12802763
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Endocarditis caused by Staphylococcus aureus with reduced susceptibility to vancomycin.
    Woods CW, Cheng AC, Fowler VG, Moorefield M, Frederick J, Sakoulas G, Meka VG, Tenover FC, Zwadyk P, Wilson KH.
    Clin Infect Dis; 2004 Apr 15; 38(8):1188-91. PubMed ID: 15095227
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Prevalence and clinical implications of Staphylococcus aureus with a vancomycin MIC of 4 microg/ml in Korea.
    Kim HB, Lee YS, Kim BS, Cha JO, Kwon SU, Lee HJ, Suh JT, Rheem I, Kim JM, Shin BM, Kim MN, Lee K, Lee CS, Kim EC, Oh MD, Choe KW.
    Microb Drug Resist; 2006 Apr 15; 12(1):33-8. PubMed ID: 16584306
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.